US FDA approves Kura Oncology's blood cancer therapy – Reuters

Written by

admin

in

  1. US FDA approves Kura Oncology’s blood cancer therapy  Reuters
  2. FDA Approves Ziftomenib in R/R NPM1-Mutated Acute Myeloid Leukemia  CancerNetwork
  3. Kura Oncology and Kyowa Kirin Announce FDA Approval of  GlobeNewswire
  4. KURA Gains FDA Approval for Key Leukemia Drug  GuruFocus
  5. FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia  Cure Today

Continue Reading

More posts